APPLICATION
ANDA210892
TYPE
ANDA
ORIGINAL APPROVAL
2018-09-14
LATEST ACTION
2023-07-12
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
LEVOLEUCOVORIN CALCIUMPrescription
LEVOLEUCOVORIN CALCIUM EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) · SOLUTION · INTRAVENOUS
LEVOLEUCOVORIN CALCIUMPrescription
LEVOLEUCOVORIN CALCIUM EQ 250MG BASE/25ML (EQ 10MG BASE/ML) · SOLUTION · INTRAVENOUS
Approval history
2023-07-12Labeling · Supplement 3 · standardAP
2023-07-12Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.